American Society of Clinical Oncology Genitourinary (ASCO GU) cancers symposium held in San Francisco, CA between February 13 th and 15 th 2025, was host to the Panning for Gold: The Role of ctDNA as ...

Beyond improving accuracy, xAI allowed researchers to compare prognostic markers across different cancer types, unveiling ...

Discover how AI is transforming urological cancer care with improved diagnosis, personalized treatments, and enhanced patient ...

MiR-371a-3p demonstrates high sensitivity and specificity, outperforming traditional tumor markers in testicular cancer diagnosis and monitoring. MiR-371a-3p shows potential in early relapse detection ...

Checking yourself for symptoms of cancer is different to cancer screening. Screening means testing people for early stages of a disease before they have any symptoms. There is no national screening ...

Researchers found that a combination therapy of two drugs disrupts this pathway, helping to suppress the creation of cancer cells and tumor growth. This combo of medications includes a statin ...